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understanding how to control cell fate is crucial in biology, medical science and engineering.   
In this study, we introduce a method that uses an intracellular protein as a trigger for regulating 
human cell fate. The on/oFF translational switches, composed of an intracellular protein L7Ae 
and its binding RnA motif, regulate the expression of a desired target protein and control two 
distinct apoptosis pathways in target human cells. Combined use of the switches demonstrates 
that a specific protein can simultaneously repress and activate the translation of two different 
mRnAs: one protein achieves both up- and downregulation of two different proteins/pathways. 
A genome-encoded protein fused to L7Ae controlled apoptosis in both directions (death or 
survival) depending on its cellular expression. The method has potential for curing cellular 
defects or improving the intracellular production of useful molecules by bypassing or rewiring 
intrinsic signal networks. 
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I
n human cells, the specific regulation of target protein production 
at the post-transcriptional level has a significant role in deter-
mining cellular phenotypes, such as growth, proliferation, dif-
ferentiation or programmed cell death (apoptosis)1–3. For instance, 
several studies comparing the amounts of expressed mRNAs and 
proteins in eukaryotic cells have demonstrated that expression of 
an mRNA only weakly correlates with that of the corresponding 
protein, indicating that protein expression is regulated not only at 
the transcriptional level but also at multiple post-transcriptional 
steps, including translational regulation and mRNA/protein degra-
dation1,4–6. Although many synthetic methods have been reported 
for controlling transcription7–11, only a few methods for controlling 
translation have been reported so far11–16.
A system that allows an endogenously expressed molecule such 
as a protein to control the expression level of a target gene would 
be especially advantageous. A method in which a specific protein 
produced in a cell can directly and quantitatively regulate the pro-
duction of target protein(s) could be used to bypass or rewire intrin-
sic signalling networks and to construct novel cascades or feedback 
circuits for controlling cell functions (Fig. 1a)17,18.
Synthetic chimeric proteins have been used to rewire cell sig-
nalling pathways to control cell phenotype19–21. For example, signal 
transduction by the receptor tyrosine kinase ErbB2 was rewired by 
fusing SH2 or PTB domains of the adaptor proteins Grb2 and ShcA 
to the death effector domain of FADD (Fas-Associated protein with 
Death  Domain)22.  In  this  system,  the  chimeric  adaptors  relayed 
the signal from epidermal growth factor (EGF) to the caspase 8-
dependent apoptotic pathway to induce cell death. However, the 
controllable signalling pathways are limited to those using the avail-
able adaptor proteins. It also remains unknown whether a protein 
expressed in cells can be used as a triggering signal for regulating 
the expression of a desired protein in these systems.
In this study, we report advanced protein-driven translational 
regulatory  ON/OFF  systems  for  controlling  the  fate  of  human   
cells (Fig. 1a,b). The design of the OFF system was based on our   
previously reported translational repression system15 consisting of 
an archaeal ribosomal protein, L7Ae, and its binding RNA motif, 
box C/D kink-turn (Kt)23. In the OFF system, L7Ae expressed in 
human cells directly and quantitatively inhibits the translation of a 
target gene. A new translational activation (ON) system triggered by 
L7Ae has also been developed for regulating the processing of short 
hairpin RNAs (shRNAs). We were able to efficiently control apop-
tosis in human cells with each system individually and in combina-
tion. In conclusion, we have shown here a new approach for deter-
mining human cell fate by using a specific genome-encoded protein 
that serves as an index of the cellular environment (Fig. 1a).
Results
Quantitative  translational  repression  in  living  cells.  We  first 
investigated  whether  we  could  observe  quantitative  translational 
control  by  L7Ae  in  individual  living  cells.  Two  plasmids  were 
constructed:  pKt-GFP-I-CFP,  in  which  the  mRNA  contains  the 
box C/D Kt motif incorporated upstream of the AUG codon of the 
EGFP  coding  sequence,  and  pdKt-GFP-I-CFP,  which  contains  a 
defective Kt motif. For pKt-GFP-I-CFP, EGFP production is under 
the control of the expression of L7Ae because of the interaction 
between L7Ae and the Kt motif. As ECFP production from IRES 
is independent of L7Ae, the ratio of the EGFP and ECFP signals 
indicates  the  level  of  translational  repression  (Supplementary 
Fig.  S1a).  The  red  fluorescent  protein  (AsRed2)  was  fused  with 
L7Ae  (AsRed2-L7Ae)  to  quantify  the  expression  level  of  L7Ae 
for normalization of the data. Overall translational repression effi-
ciencies across the entire population of cells confirmed that the OFF   
system is highly efficient and selective (Supplementary Fig. S1b). 
We  next  analysed  the  efficiency  in  individual  cells.  The  results 
indicate that EGFP production from the Kt-GFP-I-CFP mRNA was 
repressed quantitatively and selectively in individual cells depending 
on the expression level of L7Ae (Supplementary Fig. S1c). Thus, we 
conclude that the efficiency of translational regulation corresponds 
to the expression level of the input L7Ae protein.
Reprogramming cell death pathways with the OFF system. The 
OFF system was applied for controlling human cell fate by modulat-
ing the translation of apoptosis regulatory proteins (Fig. 1b). The 
mitochondrial-dependent apoptosis pathways were used to control 
intrinsic apoptosis pathways (Fig. 1b, Bcl-xL/Bim-dependent path-
ways) because the balance between proapoptotic (that is, Bim) and 
antiapoptotic (that is, Bcl-xL) Bcl-2 family proteins determines cell 
fate24. Namely, the control of apoptosis pathways by gene regulation 
requires strict expression balance between pro- and antiapoptotic 
proteins25. For instance, the leaky expression of a proapoptotic gene 
makes it difficult to suppress apoptosis, as it amplifies apoptosis 
signals by positive feedback mechanism26,27. To control apoptosis 
by  L7Ae,  we  constructed  the  following  three  plasmids:  pKt-Bcl-
xL-I-GFP (an antiapoptotic agent), pdKt-Bcl-xL-I-GFP (a negative 
control plasmid containing a defective Kt) and a plasmid encoding 
Bim (pBim, a proapoptotic agent) (Fig. 2a, Supplementary Fig. S2). 
Western blot analysis showed that L7Ae expressed in HeLa cells effi-
ciently represses the expression of Bcl-xL from pKt-Bcl-xL-I-GFP 
(Fig. 2b, lane 5), but has no effect on the defective Kt mutant, pdKt-
Bcl-xL-I-GFP (Fig. 2b, lane 7). Flow cytometric analysis confirmed 
that expression of Bcl-xL from pKt- or pdKt-Bcl-xL-I-GFP efficiently 
repressed Bim-induced apoptosis in cells (Fig. 2c, lane 2 versus lane 
3 or 5). In addition, L7Ae triggered an apoptosis-inducing signal 
in the corresponding cells by promoting the translational regula-
tion of Bcl-xL. Expression of L7Ae induced apoptosis specifically in 
cells containing both pBim and pKt-Bcl-xL-I-GFP (Fig. 2c, lane 4;   
Supplementary Fig. S3). An analysis of cell morphology confirmed 
that L7Ae induced apoptosis by repressing Bcl-xL expression in tar-
get cells (Fig. 2d, left, middle picture), whereas the normal pheno-
type was observed for cells containing the control plasmid (Fig. 2d,   
right,  middle  picture).  Thus,  L7Ae  expressed  in  cells  containing 
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Figure 1 | Schematic diagram for regulation of cell death by protein-
driven RNA ON/OFF switches. (a) schematic representation of the 
outcome of this study. A protein encoded in genome drives translational 
switches and regulates intrinsic apoptosis signal cascade to control cell 
fate (death or survival). (b) schematic diagram of the circuit connected to 
intrinsic apoptosis signal cascades regulated by the switches. Two distinct 
(mitochondria dependent and independent) apoptosis pathways controlled 
by L7Ae. L7Ae strictly regulates the production of apoptotic regulatory 
proteins (that is, Bcl-xL, Bim, FADD) involved in the complex intrinsic 
apoptosis signal cascades. several steps of signal-transduction cascades 
and activation of a set of caspases are required to determine cell death.ARTICLE     
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Kt-Bcl-xL mRNA induces apoptosis by repressing the expression of 
Bcl-xL.
To  demonstrate  the  modularity  of  the  OFF  switch,  we  con-
structed an alternative system to direct cell fate towards survival by 
regulating a mitochondria-independent apoptotic pathway (Fig. 1b,   
FADD-dependent  pathway).  The  expression  of  FADD  has  a 
critical role in inducing apoptosis in this pathway (Fig. 1b, right;   
Supplementary Fig. S4)28. We attempted to downregulate apopto-
sis by repressing the production of FADD with the L7Ae system 
(Supplementary Fig. S5a). L7Ae downregulated apoptosis effectively 
and specifically by repressing translation of FADD derived from 
pKt-FADD plasmid (Supplementary Fig. S5b–f). These results indi-
cate that by repressing the expression of either anti- or proapoptotic 
proteins, the OFF system can steer the apoptosis pathway towards 
death or survival, respectively.
Synthetic translational activation of a target mRNA. Like the OFF 
system, the protein-triggered translational activation system (ON 
system) should work as a ‘protein–protein information converter’ 
that transmits information carried by an input protein (for exam-
ple, L7Ae) to the desired output protein (for example, Bcl-xL). Such 
converters are useful for bypassing intrinsic cell signalling pathways 
or constructing synthetic signalling pathways (Fig. 1)19,20. To con-
struct the ON system in human cells, we designed and constructed 
a synthetic shRNA29–31 containing an siRNA and the Kt motif in its 
stem and loop regions, respectively (Figs 1 and 3a; Supplementary 
Fig. S6). We will refer to this construct as Kt-shRNA. In this system,   
the Kt-shRNA is designed to result in specific degradation of a 
target mRNA by RNA interference (RNAi). Conversely, cellularly 
expressed L7Ae binding to Kt-shRNA is expected to interfere with 
Dicer-dependent cleavage of the shRNA, resulting in L7Ae-control-
led protection of the target mRNA (Fig. 3a).
Before performing cell fate control experiments, we confirmed 
that the Kt-shRNA, which targeted the EGFP gene for RNAi (Kt-
Sh-GFP;  Fig.  3b),  interacted  specifically  with  recombinant  L7Ae   
in vitro (Fig. 3c). We observed that the catalytic activity of Dicer was 
efficiently blocked by the RNA–protein (RNP) interaction (Fig. 3d). 
Two shRNA-coding plasmids, pKt-Sh-GFP and the corresponding 
negative control plasmid, pdKt-Sh-GFP, containing a defective Kt, 
were tested to show that they effectively downregulated the expres-
sion of EGFP at both the protein and the mRNA levels (Figs 3e,f). 
As expected, L7Ae expressed in HeLa cells could upregulate EGFP 
expression  by  binding  to  pKt-Sh-GFP,  but  it  did  not  affect  the   
downregulation of EGFP expression by pdKt-Sh-GFP (Fig. 3f).
To regulate cell fate, we prepared three shRNA-coding plasmids 
that targeted the Bcl-xL gene: pSh-Bcl-xL (positive control), pKt-
Sh-Bcl-xL and pdKt-Sh-Bcl-xL (Fig. 4a). L7Ae selectively inhibited 
the activity of Dicer on Kt-Sh-Bcl-xL RNA in vitro, but not on dKt-
Sh-Bcl-xL RNA (Fig. 4b). Western blotting showed that transfection 
of pKt-Sh-Bcl-xL or pdKt-Sh-Bcl-xL repressed expression of Bcl-xL 
in cells after 24 h as effectively as the positive control, pSh-Bcl-xL  
(Fig. 4c, lanes 7 and 8). Conversely, L7Ae protected the expression of 
Bcl-xL from repression by pKt-Sh-Bcl-xL selectively and effectively 
(Fig. 4c, lane 5). The results indicate that the interaction between 
L7Ae and Kt-shRNA inhibits RNAi activity, which results in trans-
lation of the protected target mRNA.
The  ON  system  was  used  to  control  cell  fate  by  activating   
Bcl-xL translation in the presence of L7Ae. Flow cytometric (Fig. 4d, 
lane 4) and cell morphology (Fig. 4e, left, bottom picture) analyses 
showed that the system repressed Bim-induced apoptosis by activat-
ing Bcl-xL expression (Fig. 1b). Taken together, the data indicate 
that the synthetic translational ON and OFF systems can each con-
trol cell fate in the desired direction (death or survival) by modulat-
ing translation of the target mRNAs.
Simultaneous control of cell fate by both ON and OFF systems. 
We  next  attempted  to  simultaneously  repress  the  translation  of 
one mRNA and activate expression of a second mRNA in human 
cells by using L7Ae. Plasmids encoding AsRed2, designed to serve 
as a repressible gene (AsRed2-OFF), and EGFP, designed to serve 
as an activating gene (EGFP-ON), were constructed. L7Ae expres-
sion  simultaneously  and  selectively  repressed  the  translation  of 
AsRed2 and activated EGFP, which we confirmed by flow cytometry   
(Figs 5a,b) and fluorescence microscopy (Fig. 5c). The results indi-
cate  that  a  single  protein  simultaneously  represses  and  activates 
translation of two different mRNAs in human cell.
The  combined  use  of  the  ON/OFF  systems  was  tested  for   
controlling apoptotic pathways in human cells. The OFF and ON 
switches  were  designed  to  repress  proapoptotic  Bim  (Bim-OFF) 
and  to  activate  antiapoptotic  Bcl-xL  (Bcl-xL-ON),  respectively   
(Fig. 1b). As expected, L7Ae simultaneously repressed Bim expres-
sion  and  activated  Bcl-xL  expression  to  successfully  modulate   
apoptosis (Fig. 6a, lane 3; Fig. 6b, top left). We were able to unidirec-
tionally control human cell fate by appropriately connecting the two 
systems to the existing signalling networks.
Control of apoptosis by a protein encoded in genome. Finally, 
we investigated to see whether a protein of interest encoded in the 
genome quantitatively controls apoptosis pathways as a function 
of the protein expression. The insertion of L7Ae into the genome 
allows us to use L7Ae as a molecular tag for a protein of interest. As 
a pilot system, we attempted to quantitatively regulate apoptosis by 
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Figure 2 | Regulation of the apoptosis pathway using the OFF system. 
(a) schematic illustration of the on/oFF states of the switch. In cells that 
do not express L7Ae, translated Bcl-xL protein binds to Bim to prevent 
apoptosis (on state). L7Ae represses translation of Bcl-xL, and the 
apoptosis signal from Bim can proceed (oFF state). (b) Western blotting 
analysis of Bcl-xL expression in HeLa cells co-transfected with pL7Ae and 
p(d)Kt-Bcl-xL-I-GFP. Bcl-xL and L7Ae were detected using anti-Bcl-xL and 
anti-myc antibodies, respectively. (c) Flow cytometric analysis performed 
24 h after co-transfection with pBim and the plasmids described in b. The 
data are presented as the mean ± s.d. of triplicate experiments. (d) Phase 
microscopic images of the cells analysed in c. A scale bar represents 
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controlling the expression level of an input protein (L7Ae-tagged 
red  fluorescent  protein:  DsRed-L7Ae)  encoded  in  the  genome.   
A stable cell line (T-REx HeLa) was used for the conditional expres-
sion of DsRed-L7Ae in the presence of tetracycline. Western blot-
ting analysis confirmed that the repression of Bcl-xL production 
depends quantitatively on the expression of DsRed-L7Ae (Fig. 7a). 
Moreover, apoptosis of the target cells was induced by the expression 
of DsRed-L7Ae in a dose-dependent manner (Fig. 7b). We were also 
able to repress apoptosis by controlling FADD expression by using 
DsRed-L7Ae expressed from the genome (Supplementary Fig. S7). 
Thus, it seems certain that a specific protein encoded in the genome 
can drive the translational regulatory systems to control cell fate.
Discussion
In this study, we have shown that the RNP switch containing the 
L7Ae–Kt RNP interaction motif enables the control of human cell 
phenotype.  A  specific  protein  (L7Ae  or  L7Ae-tagged  protein  of 
interest) expressed in cells repressed and activated translation of 
specific mRNAs coding the proteins (that is, Bcl-xL, Bim, FADD) 
involved in the signal-transduction cascades. Moreover, the protein- 
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Figure 3 | Protein-driven ON system. (a) schematic illustration of the on/oFF states. (b) sh-GFP targeting the EGFP gene. The sequence in red is 
complementary to EGFP mRnA (1). sh-n was designed not to knockdown any gene and encodes a stop codon (in yellow) in every frame (2). We 
designed Kt-sh-GFP by incorporating the Kt motif into the loop region of the sh-GFP (3). dKt-sh-GFP is defective for the Kt motif in the loop region (4). 
(c) Determination of the binding affinity of Kt-sh-GFP (40 nm) and L7Ae (0–640 nm) using the gel shift assay. Kt-sh-GFP and L7Ae were mixed in 
transfection buffer, opti-mEmI (Invitrogen), and separated in the gel shift assay. (d) The specific binding of Kt and L7Ae repressed Dicer cleavage activity 
for Kt-sh-GFP. In the presence of L7Ae, Kt-sh-GFP and L7Ae formed an RnP complex and prevented Dicer cleavage, yet the mutant dKt-sh-GFP was still 
cleaved. (e) The relative concentration of EGFP mRnA. (f) The intensity of EGFP fluorescence in HeLa cells stably expressing EGFP (HeLa-GFP). These 
indicated that L7Ae-specific binding to Kt-sh-GFP repressed the knock down function of Kt-sh-GFP and, as a result, inhibited EGFP mRnA degradation and 
reactivated EGFP expression in HeLa-GFP cells. For e and f, the error bar indicates the standard deviation of three independent samples. sh-GFP and sh-n 
were used for positive and negative controls of EGFP knockdown, respectively.ARTICLE     
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driven ON/OFF systems can control the intrinsic apoptosis signal-
ling circuits (that is, mitochondria-dependent and -independent   
apoptosis  pathways)  to  determine  cell  phenotype  (cell  death)   
(Figs 1a,b). The strict apoptotic control in this study is attributed to 
the efficient gene regulation by the RNP switches (Figs 2, 4 and 5; 
Supplementary Fig. S1), indicating that it serves as a versatile switch 
in other applications. As a pilot system, a protein of interest fused 
to L7Ae that is integrated in the genome quantitatively controlled 
apoptosis pathways (Fig. 7, Supplementary Fig. S7), indicating that 
it is feasible to construct a system for controlling phenotype of cell 
as a function of changes in the cellular environment (that is, expres-
sion of a specific protein) in general (Fig. 1a).
Small molecules, such as tetracycline or theophylline, have been 
used  as  triggers  for  synthetic  translational  regulation.  The  most 
popular  system  using  RNA  aptamers  for  theophylline  has  been 
used to determine the activation (ON) or repression (OFF) of gene 
expression in bacteria and yeast cells12,32,33. Efficient synthetic genetic 
switches triggered by the small molecule have also been constructed 
by combining RNAi regulatory systems with repressor proteins in 
mammalian  cells34.  These  methods  are  versatile  and  universally 
applicable. However, the control of cell function depending on the 
expression level of a particular gene of interest is extremely difficult 
by using a small molecule as an input signal.
Our protein-driven RNP switches are advantageous for the use 
in the signal-transduction cascades because protein molecules can 
be used as both input and output signals that is impossible for small 
molecule-based  systems.  For  instance,  an  L7Ae–Kt  interaction-
based translational auto-feedback system could allow the sophisti-
cated control of protein production depending on the cellular envi-
ronment in a manner similar to naturally occurring translational 
feedback  systems35.  In  our  preliminary  experiments,  cellularly 
expressed L7Ae modulated its own translation level by binding to 
the Kt motif of the mRNA (Stapleton, J.A. et al., unpublished data). 
Thus, the ON/OFF switch could serve as a unique tool for accu-
rately controlling cell fate because expression levels from particular 
mRNAs can vary in a spatiotemporal manner36 to induce a variety 
of cell phenotypes37.
Proteins other than L7Ae are potentially usable as new regula-
tors for the system as follows: (1) The L7Ae protein could be used 
to tag other proteins of interest, and (2) a variety of RNA–protein 
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binding motifs, including naturally occurring and in vitro-selected 
RNA aptamers, could be used for constructing new translational 
switches38. RNP interaction motifs can be seen as a new molecular 
resource for constructing libraries of interoperable components and 
modules39. Accordingly, development of a set of new RNP inter-
action motifs could be useful for next-generation and real-world 
application of synthetic gene networks9,15,39,40.
For  instance,  in  vitro-selected  aptamers  could  directly  sense 
the expression of target marker proteins (for example, Bcl-xL, the 
expression level of which is known to be upregulated in certain   
cancer  cells),  and  control  the  expression  of  the  desired  output   
proteins (for example, activation of a cell killer gene; Supplementary 
Fig. S8). Thereby, the switch could induce apoptosis in the target 
cancer cells. As another example, our RNP switches could be used 
for controlling the expression of multiple genes to produce use-
ful molecules40,41, because the switches simultaneously repress and   
activate translation of different mRNAs as a function of the expres-
sion of specific proteins in living cells. The combined use of our RNP 
switch and other established regulatory systems based on transcrip-
tional control42, modular engineering of chimeric proteins19,43 or 
small molecule-based riboswitches12,32,33,44–46 could further enhance 
the efficacy of the system when multiple actions are required to 
assure the outcome.
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Figure 5 | Simultaneous translational repression and activation  
of two fluorescent proteins by synchronized ON/OFF switches.  
(a) simultaneous translational activation and repression of EGFP and 
AsRed2 by synchronized on/oFF switches. The fluorescence intensity  
of the transfected cells was analysed by flow cytometry. These dot plot 
data correspond to the fluorescent microscopic images in Figure 5c.  
(b) Flow cytometric analysis of the simultaneous regulation of EGFP-on 
and AsRed2-oFF switches by L7Ae. The efficiencies of translation  
were normalized to control translational rates in the absence of pL7Ae 
(AsRed2-oFF) or in the presence of 0.3 µg of pL7Ae (EGFP-on). The 
results are presented as the mean ± s.d. of triplicate experiments. Green 
solid line with circles; EGFP relative intensity (Kt), green dashed line  
with triangles; EGFP relative intensity (dKt), red solid line with circles; 
AsRed2 relative intensity (Kt), red dashed line with triangles; AsRed2 
relative intensity (dKt). (c) merged fluorescent microscopic images of  
cells that contained EGFP-on and AsRed2-oFF switches. A scale bar 
represents 200 µm.
Figure 6 | Simultaneous translational repression and activation of 
apoptotic proteins by synchronized ON/OFF switches. (a) Regulation 
of apoptosis by the synchronized Bcl-xL-on and Bim-oFF switches. Cells 
that contain Kt-Bim and Kt-sh-Bcl-xL were protected from Bim-induced 
apoptosis by expressing L7Ae (lane 3), whereas cells that contain dKt-Bim 
and dKt-sh-Bcl-xL induced apoptosis (lane 6). The cells were analysed 
by using flow cytometry. Kt-on/oFF switches are shown in red. The 
results are presented as the mean ± s.d. of triplicate experiments. (b) 
Cell morphology analysis of Figure 6a by phase microscopy. scale bars 
represent 200 µm.
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Figure 7 | Quantitative regulation of apoptosis by L7Ae-DsRedM protein 
derived from DNA integrated into genome. (a) Western blotting analysis 
of cell lysates 24 h after transfection with pKt-Bcl-xL-I-GFP (or pdKt-Bcl-xL-
I-GFP) and pBim in the absence or presence of tetracycline (0–15 ng ml − 1) 
using anti-Bcl-xL antibody. (b) Flow cytometric analysis of the same 
cells. Cells positive for EGFP and Pacific Blue were considered dead. Blue 
column, Kt; yellow column, dKt. The results are presented as the mean ± s.
d. of triplicate experiments.
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Methods
Cell culture and treatments. HeLa cells and HeLa-GFP cells were cultured at 37 °C 
in 5% CO2 in DMEM/F-12 (Dulbecco’s modified Eagle’s medium: Nutrient Mixture 
F-12) 1:1 mixture (Invitrogen), supplemented with an antibiotic solution (A5955, 
Sigma) and 10% calf bovine serum (CBS, MP Bioscience) or fetal bovine serum 
(CCB). HeLa-GFP cells were additionally supplemented with 50 µg ml − 1 of Hygro-
mycin B (Invitrogen). The DsRed-L7Ae-inducible cell line (T-REx HeLa-DsRed-
L7Ae) was established previously15 as follows. T-REx HeLa cells (Invitrogen), 
cultured in fresh medium supplemented with 10% CBS (#2001H, MP Biomedicals), 
were transfected with pcDNA4/TO/DsRed-L7 containing the tetracycline-regulat-
able promoter and the DsRedM-L7Ae gene. After 24 h, the medium was replaced 
with fresh medium supplemented with 10% CBS, 5 µg ml − 1 blasticidin (Invivogen) 
and 100–200 µg ml − 1 zeocin (Invitrogen) for selection. The cells were cultured in 
selective medium every 3–4 days until foci could be identified. The selected cells 
were cloned using a cell sorter (FACS Aria, BD Biosciences). The clone exhibiting 
the highest expression level of DsRedM-L7Ae in the presence of Tet was confirmed 
by western blotting and named H5. The H5 cells were cultured in DMEM/F-12  
supplemented with 10% CBS, 5 µg ml − 1 blasticidin and 150 µg ml − 1 zeocin.
Transfection. Cells were plated into appropriate multi-well plates. After 1 day,  
the 70–90% confluent cells were transfected with plasmids using Lipofectamine 
2000 according to the standard protocols included in the Lipofectamine 2000 
kit (Invitrogen). After 4 h of transfection, the medium was replaced with fresh 
medium if needed.
DNA preparation. All DNA templates and primers were purchased from 
Hokkaido System Science or Gene Design. PCR amplifications were carried out 
using Ex Taq DNA polymerase (TAKARA BIO) or KOD-PLUS-DNA polymerase 
(TOYOBO).
Apoptosis assay. Apoptotic and dead cells were stained with Pacific Blue-labelled 
annexin V according to the standard protocols of the Vybrant Apoptosis Assay Kit 
#14 (Invitrogen). Dead cells were additionally stained by 7-AAD (Invitrogen) if 
needed. The stained cells were analysed on a FACS Aria. A 405 nm semiconduc-
tor laser was used for excitation of the Pacific Blue, and a 488 nm laser was used for 
EGFP, DsRedM, AsRed2 and 7-AAD. The 450/40 nm, 530/30 nm and 695/40 nm 
bandpass filters were used for collection of the fluorescent signals from Pacific 
Blue, EGFP and 7-AAD, respectively. When EGFP and DsRedM (or AsRed2) were 
expressed simultaneously, a 695/40 nm bandpass filter was used for the signals from 
DsRedM (or AsRed2); otherwise, a 616/23 nm bandpass filter was used. The remaining 
cells were collected and stored at  − 20 °C for analysis by western blotting, if needed.
Translational repression assay of apoptosis regulatory proteins. For western 
blotting analysis of repression of Bcl-xL in cells, HeLa cells (1×105 per well) were 
seeded onto 12-well plates. pL7Ae (0.4 µg) and pKt-Bcl-xL-I-GFP (or dKt-Bcl-xL-
I-GFP, 0.2 µg) were co-transfected into HeLa cells. A blank plasmid, pcDNA that 
stands for pcDNA3.1-MycHisA (Invitrogen), was used as a control. Twenty-four 
hours after transfection, the cells were collected by trypsinization and Bcl-xL was 
detected using an anti-Bcl-xL antibody. For analysis of apoptosis regulated by 
Bcl-xL and Bim, HeLa cells were co-transfected as described above, except that 
the cells were additionally co-transfected with 0.2 µg of pBim. After 24 h, collected 
cells were stained by Pacific Blue-labelled annexin V and 7-AAD and analysed on 
a FACS Aria. Only EGFP-positive cells were analysed to eliminate debris, dust or 
untransfected cells. Pacific Blue-positive cells were considered dead.
For quantitative regulation of apoptosis, the DsRed-L7Ae-inducible cell line 
(3×105 per well) was used instead of HeLa cells. Cells were co-transfected with 
0.4 µg of pKt-Bcl-xL-I-GFP (or dKt-Bcl-xL-I-GFP) and 0.4 µg of pBim using 2 µl 
Lipofectamine 2000. After 4 h, expression of DsRed-L7Ae was induced by tetra-
cycline (Invitrogen) at 0–15 ng ml − 1. After 24 h, the cells were stained by Pacific 
Blue-labelled annexin V and analysed on the FACS Aria.
To confirm proapoptotic activities of FADD and its pathway, DsRed-L7Ae-
inducible cell lines (3×105 per well) were seeded onto 12-well plates. The cells were 
co-transfected with 0.9 µg of pKt-FADD and 0.4 µg of pEGFP-N1 in the presence 
or absence of 20 µM of Z-V-FMK (Sigma). For analysis of apoptosis regulated 
by FADD, HeLa cells (5×105 per well) were seeded onto six-well plates. The cells 
were co-transfected with 0.5 µg of pKt-FADD (or pdKt-FADD) and 1 µg of pL7Ae 
and collected after 24 h. Expression of FADD in the cells was detected by western 
blotting using an anti-c-Myc antibody. To eliminate untransfected cells, cells were 
additionally co-transfected with 0.2 µg of pEGFP-N1 for flow cytometric analysis. 
The collected cells were stained by Pacific Blue-labelled annexin V and 7-AAD and 
subjected to flow cytometric analysis. Pacific Blue-positive cells were considered 
dead.
Dicer-dependent shRNA in vitro cleavage assay. Kt-Sh-Bcl-xL or dKt-Sh-Bcl-xL 
(40 nM) and the purified L7Ae protein (0, 800 or 1,600 nM) were mixed with 1 µl 
of 10 mM ATP, 0.5 µl of 50 mM MgCl2, 4 µl of Dicer Reaction Buffer (Genlantis), 
2 µl of 0.5 U µl − 1 Recombinant Human Dicer Enzyme (Genlantis), and water (up to 
10 µl). The mixtures were incubated at 37 °C for 14 h and incubation was stopped 
with 2 µl of Dicer Stop Solution. The mixtures were separated by 15% native PAGE 
at 4 °C for 50 min and the gel was stained with SYBER-Green (TAKARA BIO). The 
fluorescence of the stained RNA was detected by FLA-7000 (Fujifilm) (Fig. 4b). Kt-
Sh-GFP and dKt-Sh-GFP were also analysed using the above procedure (Fig. 3d).
Translational activation assay of Bcl-xL. To examine the re-activation efficiency 
of Bcl-xL translation triggered by Kt-L7Ae binding, we co-transfected HeLa cells 
(3×105 per well) grown for 1 day in 12-well plates with pBcl-xL, p(d)Kt-Sh-Bcl-xL 
and pL7Ae using 2.5 µl of Lipofectamine 2000. Twenty-four hours after transfec-
tion, Bcl-xL was quantified by western blotting analysis. To examine the efficiency 
of cell fate determination through the control of Bcl-xL translation triggered by 
Kt-L7Ae binding, we co-transfected HeLa cells (0.5×105 per well) grown for 1 day 
in 24-well plates with 0.2 µg of pBim, 0.2 µg of pBcl-xL, 0.3 µg of p(d)Kt-Sh-Bcl-xL 
and 0.2 µg of pAsRed2-L7Ae using 1.25 µl of Lipofectamine 2000. Twenty-four 
hours after transfection, following a cell morphology analysis, the cells and me-
dium were collected and stained with Pacific Blue-labelled annexin V as described 
in the apoptosis assay. The populations of apoptotic and dead cells, which exhibited 
high fluorescence intensity of Pacific Blue, were analysed using a flow cytometer.  
To eliminate abnormal cells, those cells whose fetal calf serum and Supercon-
ducting Super Collider signal scopes were identical to those of untreated HeLa 
cells were selected for the calculation of mean intensities. The red fluorescence of 
AsRed2-L7 was used as a marker for co-transfected cells. pSh-Bcl-xL and pSh-N 
were used for positive and negative controls of Bcl-xL knockdown, respectively.
Synchronized control of ON/OFF translational switches. For the synchronized 
control of AsRed2-OFF and EGFP-ON switches triggered by Kt-L7Ae binding in 
the same cells, we co-transfected HeLa cells (0.8×105 per well) grown for 1 day 
in 24-well plates with 0, 0.05, 0.1, 0.2, 0.3 µg of pL7Ae and pcDNA (total amount 
0.3 µg), 0.1 µg of pEGFP, 0.3 µg of p(d)Kt-Sh-GFP and 0.1 µg of p(d)Kt-AsRed2-I-
CFP with 1.5 µl of Lipofectamine 2000. Transfection for fluorescent microscopic 
analysis was performed similarly, but with the replacement of p(d)Kt-AsRed2-I-
CFP with p(d)Kt-AsRed2. Twenty-four hours after transfection, cells and medium 
were collected and re-suspended in medium. To measure the EGFP and AsRed2 
fluorescence intensities, the CFP-expressing cells (as a positive control for the 
transfected cells) were analysed by a flow cytometer. The abnormal cells were  
eliminated as described in the translational activation assay. For the simultaneous 
control of Bim repression and Bcl-xL activation by mixing the Kt-L7Ae OFF and 
ON switches, we co-transfected HeLa cells (1.0×105 per well) grown for 1 day in 
24-well plates with 0.2 µg of pBcl-xL, 0.2 µg of pAsRed2-L7Ae, 0.2 µg of p(d)Kt-
Bim and 0.3 µg of p(d)Kt-Sh-Bcl-xL (the total amount of transfected plasmids 
was compensated with pcDNA up to 0.9 µg) with 1.25 µl of Lipofectamine 2000. 
Twenty-four hours after transfection, following cell morphology analysis, the cells 
and medium were collected and stained with Pacific Blue-labelled annexin V  
as described in the apoptosis assay. The populations of apoptotic and dead cells, 
which exhibited high fluorescence intensity of Pacific Blue, were analysed using a 
flow cytometer. The red fluorescence of AsRed2-L7 was used as a marker for  
co-transfected cells. 
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